Silver Book Fact

According to the Pharmaceutical Research and Manufacturers of America, 146 new medicines are being developed for heart disease and stroke. They include 17 for stroke, 16 for congestive heart failure, 10 for high blood pressure, 8 for heart attacks and 13 for arrhythmias.

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Following the current path, pulmonary condition cases will increase by 31.3% between 2003 and 2023. If an alternative path is taken, there will be 9.1% fewer pulmonary condition cases.  
  • Survival rates of SAS patients ages 80+ with and without SAVR
     
  • The projected economic value of eliminating deaths from stroke is $7.6 trillion.  
  • Assuming that Medicare Part D covers about 37% of beneficiaries’ drug costs, it is estimated that providing post-myocardial infarction Medicare beneficiaries with full coverage for combination pharmcotherapy will save more…  
  • Development and widespread use of left ventricular assist devices could result in a 50% decrease in heart failure-related hospitalizations.